Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2023 Sep 28;17(9):e0011536. doi: 10.1371/journal.pntd.0011536

Epidemiological and genomic investigation of chikungunya virus in Rio de Janeiro state, Brazil, between 2015 and 2018

Filipe Romero Rebello Moreira 1,2, Mariane Talon de Menezes 1, Clarisse Salgado-Benvindo 1,3, Charles Whittaker 2, Victoria Cox 2, Nilani Chandradeva 2, Hury Hellen Souza de Paula 4, André Frederico Martins 4, Raphael Rangel das Chagas 4, Rodrigo Decembrino Vargas Brasil 4, Darlan da Silva Cândido 2,5, Alice Laschuk Herlinger 1, Marisa de Oliveira Ribeiro 6, Monica Barcellos Arruda 6, Patricia Alvarez 6, Marcelo Calado de Paula Tôrres 1, Ilaria Dorigatti 2, Oliver Brady 7,8, Carolina Moreira Voloch 1, Amilcar Tanuri 1, Felipe Iani 9, William Marciel de Souza 10,11, Sergian Vianna Cardozo 4, Nuno Rodrigues Faria 2,5,12,*, Renato Santana Aguiar 13,14,*
Editor: Qu Cheng15
PMCID: PMC10564160  PMID: 37769008

Abstract

Since 2014, Brazil has experienced an unprecedented epidemic caused by chikungunya virus (CHIKV), with several waves of East-Central-South-African (ECSA) lineage transmission reported across the country. In 2018, Rio de Janeiro state, the third most populous state in Brazil, reported 41% of all chikungunya cases in the country. Here we use evolutionary and epidemiological analysis to estimate the timescale of CHIKV-ECSA-American lineage and its epidemiological patterns in Rio de Janeiro. We show that the CHIKV-ECSA outbreak in Rio de Janeiro derived from two distinct clades introduced from the Northeast region in mid-2015 (clade RJ1, n = 63/67 genomes from Rio de Janeiro) and mid-2017 (clade RJ2, n = 4/67). We detected evidence for positive selection in non-structural proteins linked with viral replication in the RJ1 clade (clade-defining: nsP4-A481D) and the RJ2 clade (nsP1-D531G). Finally, we estimate the CHIKV-ECSA’s basic reproduction number (R0) to be between 1.2 to 1.6 and show that its instantaneous reproduction number (Rt) displays a strong seasonal pattern with peaks in transmission coinciding with periods of high Aedes aegypti transmission potential. Our results highlight the need for continued genomic and epidemiological surveillance of CHIKV in Brazil, particularly during periods of high ecological suitability, and show that selective pressures underline the emergence and evolution of the large urban CHIKV-ECSA outbreak in Rio de Janeiro.

Author summary

Chikungunya is a mosquito-borne viral disease that has emerged as a significant public health concern in many regions worldwide. The state of Rio de Janeiro, a key economic and tourism hub in Brazil, has experienced multiple outbreaks of chikungunya in recent years, resulting in significant morbidity and economic burden. However, our understanding of the establishment and epidemiology of chikungunya in Rio de Janeiro remains limited. We conducted an analysis of chikungunya epidemiology in Rio de Janeiro, focusing on the first four years of virus circulation in the state. We estimated the magnitude of chikungunya transmission during this period, providing evidence that the trends of incidence and transmissibility can be influenced by climatic fluctuations, which impact vector abundance. Through analysis of novel genetic data, we inferred the evolutionary history of the virus, providing evidence of molecular adaptation in the lineage circulating in Rio de Janeiro. These findings highlight the need for designing effective vector control strategies to prevent and mitigate chikungunya in Rio de Janeiro and similar settings. Further research is needed to continue monitoring viral epidemiological trends and to better understand the complex interactions between climatic factors, vector dynamics, and viral evolution in shaping the transmission of this emerging disease.

1. Introduction

Chikungunya virus (CHIKV) is an enveloped virus with a single-stranded positive-sense RNA 11.8 kb genome that belongs to the Alphavirus genus in the Togaviridae family [1]⁠. The CHIKV genome contains two open reading frames encoding four non-structural proteins (nsP1–nsP4), important for viral replication, and four structural proteins (capsid, E1–E3), necessary for virus assembly [2]. CHIKV is transmitted by the bites of infected Aedes spp. mosquitoes, mainly from the Ae. aegypti species and, to a lesser extent, the Ae. albopictus species. In humans, clinical manifestations of chikungunya include arthralgia, high fever, myalgia, headache and often exanthema. However, chikungunya may also cause long-lasting debilitating polyarthralgia [1], and can also lead to neurological complications and fatal outcomes [3]. Despite being an important public health threat with >1 billion people at risk for transmission [4], reporting of chikungunya infections often relies on syndromic surveillance, which is challenged by the co-circulation of mosquito-borne viruses that cause similar clinical symptoms, including dengue (DENV) and Zika (ZIKV) [5].

Since its first description in Tanzania in 1952, chikungunya has caused over 70 outbreaks in Africa, Asia, Americas, Europe and in Ocean Pacific Islands [4]. CHIKV can be classified into four distinct lineages: the West-African lineage, the Asian lineage, the East-Central-South-African (ECSA) genotype [6], and the Indian Ocean lineage (IOL). Chikungunya’s geographic distribution–particularly of Asian, IOL and ECSA lineages–has been expanding rapidly over the last 20 years probably due rapid urbanization, globalization of trade, and virus evolution and adaptation to local variation in the distribution of vector species [710]. For example, a single amino acid change in the E1 protein (i.e., E1-A226V) of the CHIKV IOL lineage has been linked to increase transmissibility and infectivity in Ae. albopictus and was linked with a series of severe outbreaks in Indo-Pacific Asia [1113]⁠⁠.

In 2013, the CHIKV Asian lineage was first detected in St Martin islands in the Caribbean [14]. Since then, this lineage has spread to >50 countries and territories in the Americas [14,15]⁠. In 2014, co-circulation of the Asian and ECSA lineages was detected in Brazil [16]. Local transmission of the Asian genotype was first detected in Amapá state, North Brazil, on 31 July 2014 [16]. On 25 August 2014, local transmission of the CHIKV ECSA lineage was identified in Bahia state, Northeast Brazil [16,17]. Retrospective outbreak investigations revealed that the ECSA index case in Brazil arrived in Bahia in late May 2014 from Angola [17]. This new ECSA-American lineage was then linked to large outbreaks in the Amazonas and Roraima states in North Brazil, despite earlier circulation of the Asian lineage in that region [18]. Currently, circulation of ECSA-American lineage has been confirmed in all five geographic regions of Brazil [1823], but also in Paraguay [24] and Haiti [25].

Rio de Janeiro (RJ) is the third most populous Brazilian state and a key business and touristic hub in the Americas. Due to air and fluvial connectivity and high mosquito climatic suitability (adequate levels of temperature, humidity and precipitation for mosquito occurrence) [26], the state has historically suffered large mosquito-borne viral outbreaks [27], including dengue, Zika, yellow fever and, more recently, chikungunya. Between 2013 and 2018, CHIKV has caused 403,828 confirmed infections in Brazil [28]. In 2018, RJ became the epidemic center of CHIKV in Brazil, accounting for 41% of the cases reported in the country [28]. Until 2017, only 20,251 cases had been confirmed in Rio de Janeiro, corresponding to 6% of the total case numbers reported in Brazil. The earliest autochthonous chikungunya cases were reported in November 2015, and since then two ECSA sub-lineages have been detected in Rio de Janeiro [20,21,29]. Despite the burden imposed in Rio de Janeiro, chikungunya’s evolution and transmission patterns remain poorly understood. The reliance of chikungunya diagnosis on clinical-epidemiological criteria and the scarcity of chikungunya sequence data from Rio de Janeiro, hamper our understanding of chikungunya transmission and evolution. Moreover, relevant epidemiological parameters, such as basic (R0) and time varying (Rt) reproduction numbers, which measure virus transmissibility, have not been yet previously estimated for CHIKV in Rio de Janeiro, hindering comparisons with the virus’ epidemiological dynamics in other settings.

Using genetic analysis of CHIKV newly generated and publicly available genome sequences and CHIKV traditional surveillance data, we investigated its evolution and transmission dynamics in Rio de Janeiro. We show that the large 2018 CHIKV outbreak in Rio de Janeiro was mainly caused by one dominant ECSA-American viral clade that likely persisted locally since mid-2015. In addition, we provide evidence of adaptive molecular evolution on non-structural amino acid positions, including in a lineage-defining mutation related with the dominant ECSA viral clade associated with the 2018 outbreak in Rio de Janeiro. Finally, using epidemiological modeling, we estimate basic and instantaneous reproduction numbers for CHIKV ECSA-American in Brazil, further expanding our understanding of the epidemiology of this rapidly expanding lineage.

2. Materials and methods

2.1. Ethics statement

Clinical samples were collected with formal written consent following approval of the ethical review board of Universidade do Grande Rio (approval number: 54544316.3.0000.5283).

2.2. Quantifying CHIKV transmissibility in Rio de Janeiro

The weekly aggregated epidemiological data of chikungunya laboratory-confirmed cases in RJ was obtained from the Brazilian Ministry of Health from 2014 to 2018, and then the results were presented in time series. Data was used to estimate weekly CHIKV incidence and transmissibility (reproduction number) for Rio de Janeiro between 2016 and 2018. We estimated the basic reproductive number (R0), defined as the number of secondary infections caused by an infected individual in a completely susceptible population, using data from 3 January to 13 March of 2016. We employed the exponential growth method to estimate R0 [27], which derives an estimate of R0 from the generation time distribution along with an estimate of the exponential growth rate, calculated during the earliest weeks of the outbreak where epidemic growth was approximately exponential and factors such as susceptible depletion, behavioral change or vector control are negligible. To assess changes in transmission over time in subsequent epidemics when immunity due to prior natural infection is present, we also calculated the instantaneous reproduction number (Rt), defined as the average number of secondary cases caused by an infected individual during the epidemic, provided the conditions remained as they were at time t [30]. We used an 8-week sliding-window to estimate Rt, and conducted several sensitivity analyses considering different sliding-window intervals (3 to 7 weeks). We assumed a parametric gamma distribution for the generation time (GT) with a mean of 14 days and a standard deviation of 6.4 days, based on an earlier estimate obtained during an outbreak caused by the Indian Ocean lineage [31]. We also performed sensitivity analyses with different mean GT values (10 and 20 days), keeping the standard deviation constant. All analyses were performed in R software v4.2.2 [32] with the R0 [33] and EpiEstim [30] packages.

2.3. Aedes aegypti transmission potential in Rio de Janeiro

To estimate Aedes aegypti transmission potential for RJ between 2014 and 2018, we first extracted daily values (midday) of 2m air temperature, 2m dew point temperature and total precipitation for all locations across RJ from the ERA-5 ECMWF reanalysis product [34]. We calculated relative humidity based on daily temperature and dew point estimates using the August-Roche-Magnus approximation [3537]. Each variable was then averaged over RJ and combined to calculate index P using the MVSE R package [38]. We used priors related to Ae. aegypti ecology and entomology, as described elsewhere [38]. We then aggregated resulting daily estimates to generate mean weekly estimates for index P between 2014 and 2018. Code and data used in these analyses are available in S1 File and on the project GitHub repository (https://github.com/filiperomero2/CHIKV_RJ_2015-2018, last accessed on 30 May 2023).

2.4. Sample collection, RNA extraction, and CHIKV molecular diagnosis

To assess the genetic diversity of CHIKV in Rio de Janeiro state, we generated new CHIKV genomes obtained from samples collected in the Duque de Caxias municipality, the third most populous city in Rio de Janeiro state (Fig 1A and 1B; https://cidades.ibge.gov.br/brasil/rj/duque-de-caxias/, last accessed 21 June 2022)⁠. A total of 179 samples, blood or urine, from arboviral suspected cases were collected in public health care units between July 2017 and June 2018. Viral nucleic acid extractions were performed with the QIAmp viral RNA mini kit (Qiagen, Germany), following manufacturer’s instructions. We then tested extracted RNAs by RT-qPCR for detection of ZIKV, DENV, and CHIKV using the ZDC molecular kit (Bio-Manguinhos FIOCRUZ, Brazil). Samples presenting a cycle threshold (Ct) < 38 for a given target were considered positive for CHIKV.

Fig 1. Map of Brazil and Rio de Janeiro state, state-level weekly CHIKV incidence in the 2016–2018 period and Rt estimate.

Fig 1

(A) Map of Brazil with all states colored in light gray, except for Rio de Janeiro, in green. (B) Rio de Janeiro map with municipality borders delimitation. The municipality of Duque de Caxias, where samples for genome sequencing were collected, is colored yellow. (C) State level weekly incidence data. Bars correspond to the number of CHIKV cases. (D) Estimate for Rt between 2016 and 2018 (left y-axis). The solid line indicates mean values, while the ribbon indicates the 95% confidence interval. The dashed line represents index P values, a measure of transmissibility potential for the vector Aedes aegypti (right y-axis). The dotted line marks the critical epidemic threshold (Rt = 1). Maps shapefiles were downloaded from Instituto Brasileiro de Geografia e Estatística (IBGE) at https://www.ibge.gov.br/en/geosciences/territorial-organization/territorial-meshes/18890-municipal-mesh.html (last accessed 26 June 2023).

2.5. Chikungunya virus whole-genome sequencing

We selected 34 CHIKV RNA-positive samples with Ct < 30 for viral whole-genome sequencing using the Illumina platform. Samples were distributed across the most sampled months of 2018 (March, April, and May), and one sample from 2017 was also sequenced. Amplicon target sequencing was conducted employing an amplicon-based sequencing protocol [39]. Briefly, we converted viral RNA to cDNA with SuperScript IV (Thermo Fisher Scientific), which was amplified with the Q5 DNA polymerase (New England Biolabs, UK) in two PCR reactions. Each PCR reaction contained 22 pairs of primers and generated overlapping amplicons of approximately 400 bp [39]. The amplicons covered the entire CHIKV genome and were used as input to the QIAseq 1-Step Library prep kit (Qiagen, Germany), following the manufacturer’s protocol. Libraries were normalized and equimolarly pooled at 14 pMol with 10% phiX control. Sequencing was performed on an Illumina MiSeq instrument with a V3 (600 cycles) cartridge.

2.6. Virus genome assembly

Strict quality control of raw sequencing reads was performed with Trimmomatic v.0.39 [40], which removed low-quality bases (Phred scores < 30), sequencing adapters, and short reads (<50 nucleotides). This software was also used to conservatively trim the 30 initial nucleotides from all reads, eliminating primer-related sequences. Filtered reads from each sample were then mapped against a reference CHIKV genome (NCBI accession number: KP164568.1) with Bowtie2 v2.4.2 [41]. Mapping files were sorted and indexed with samtools v1.11 [42]. Bcftools v1.11 [43] was used to call variants with a high-quality threshold (QUAL>200) and to estimate consensus genome sequences. Finally, bedtools v2.30.0 [44] was used to mask low-coverage sites (<10x). This assembly pipeline is publicly available on GitHub (https://github.com/filiperomero2/ViralUnity, last accessed 20 June 2022). The novel consensus genome sequences belonged to the ECSA lineage and were deposited to NCBI GenBank under Accession Numbers OP312936 to OP312969 (Table 1).

Table 1. Sample metadata and sequencing statistics for Duque de Caxias samples.

Sample ID NCBI accession Collection date RT-qPCR Ct Number of reads Average depth Genome coverage (%)
10 OP312936 2017-07-26 23.55 634,418 2582.12 85.84
53 OP312937 2018-03-01 19.45 738,782 4041.52 97.24
57 OP312938 2018-03-08 18.97 1,311,212 10039 98.00
66 OP312939 2018-03-15 14.73 624,422 3281.5 94.34
71 OP312940 2018-03-19 18.78 900,426 3051.64 70.50
79 OP312941 2018-03-22 17.08 924,090 4257.63 95.15
83 OP312942 2018-03-27 19.84 565,152 4016.5 96.19
89 OP312943 2018-03-29 20.08 1,520,304 7710.58 94.39
92 OP312944 2018-03-29 19.19 1,009,462 5340.61 97.68
97 OP312945 2018-04-02 19.35 1,159,296 5811.29 96.74
99 OP312946 2018-04-02 19.91 2,310,894 5509.86 84.85
101 OP312947 2018-04-02 24.94 6,875,476 45036.2 95.21
107 OP312948 2018-04-04 19.57 841,146 2703.55 84.18
110 OP312949 2018-04-05 20.46 1,365,558 3543.14 78.29
114 OP312950 2018-04-05 20.04 1,557,664 6901.02 93.02
116 OP312951 2018-04-05 19.62 663,888 3471.67 93.19
117 OP312952 2018-04-05 23.45 876,300 5417.87 90.16
120 OP312953 2018-04-16 18.07 765,232 2285.81 94.73
126 OP312954 2018-04-17 23.02 1,405,840 6905.76 87.42
128 OP312955 2018-04-19 21.72 1,365,992 4532.91 84.24
130 OP312956 2018-04-19 18.47 1,038,668 4913.46 94.99
134 OP312957 2018-04-19 22.77 2,133,788 10443.2 94.98
143 OP312958 2018-04-30 23.22 1,518,024 7322.5 91.43
149 OP312959 2018-04-30 23.77 1,034,102 1806.96 85.10
152 OP312960 2018-05-03 24.85 2,261,360 9137.28 87.06
155 OP312961 2018-05-03 24.84 1,339,770 6698.01 85.11
157 OP312962 2018-05-07 21.03 1,778,388 8387.42 89.23
159 OP312963 2018-05-07 24.37 628,560 2628.08 90.56
161 OP312964 2018-05-07 24.73 1,182,780 3850.23 89.45
165 OP312965 2018-05-09 18.83 1,150,356 6482.64 96.64
166 OP312966 2018-05-09 22.01 1,467,544 7224.4 86.22
170 OP312967 2018-05-14 24.08 1,048,464 4201.88 91.86
174 OP312968 2018-05-17 14.76 1,092,190 4108.37 95.44
181 OP312969 2018-05-23 18.75 816,186 4507.98 97.82

2.7. Maximum likelihood phylogenetic analyses

To contextualize the novel genome sequences within the global CHIKV diversity, we downloaded all CHIKV sequences with more than 8,000 nucleotides available on NCBI GenBank [45], as of 31 May 2022. Sequences without information on the country of sampling and date of collection were removed from subsequent analyses. The remaining 1,262 sequences were combined with the 34 new sequences and aligned to the CHIKV RefSeq genome (NCBI accession: NC_004162.2) with MAFFT v7.480 [46]. After manually trimming gap-rich regions, we estimated maximum-likelihood (ML) phylogenetic trees using IQ-Tree v2.1.2 [47]. We used Model-Finder [48] to determine the best-fit substitution model and the Shimoidara-Hasegawa-like approximate likelihood ratio test (SH-aLRT) [49] to assess phylogenetic node support.

A second dataset was assembled, comprehending only sequences from the ECSA-American sub-lineage. Only Brazilian sequences collected up 2018 were kept in this dataset, as a preliminary analysis indicated international sequences or those collected later were not related to the genome sequences described in this study. Sequences were aligned against the oldest available ECSA strain from Brazil (Accession number: KP164568, from Feira de Santana, Bahia state), and non-coding regions were trimmed out of the alignment. A novel ML tree was inferred, using the methods described above. Screening of recombination signals was performed using RDP4 [50].

2.8. Temporal structure of CHIKV ECSA-American nucleotide alignment

Root-to-tip regressions were used to evaluate the temporal signal available on genomes from the ECSA-American sub-lineage dataset, including only Brazilian strains. The estimated maximum likelihood phylogenetic tree was manually rooted in the oldest available ECSA strain from Brazil and regression between divergence and sampling dates was analyzed in TempEst v1.5.3 [51]. To optimize the temporal signal, outliers were conservatively defined as sequences whose regression residuals exceeded more or less than two times the interquartile range of the residual distribution, and 51 sequences were removed. A novel ML tree inference and root-to-tip regression were performed on the filtered ECSA-American sub-lineage dataset (n = 148).

2.9. Bayesian phylogenetic analyses

To investigate the evolutionary origins of CHIKV in Rio de Janeiro, we used Bayesian coalescent and phylogeographic models available in BEAST v1.10.4 [52,53]. Analyses were run using a HKY+G4 nucleotide substitution model [54,55], a strict molecular clock model, and a flexible skygrid tree prior [56]. The cut-off for the skygrid model was set at 4.22 years, following a preliminary estimate of the time of the most recent common ancestor (tMRCA) obtained from TempEst (x-axis intercept in the regression). The number of grid points was set to match the number of months within the tree temporal span between the tMRCA and the earliest tip (n = 51). We also performed an alternative analysis with the uncorrelated relaxed clock model with lognormal rate distribution (UCLN) [57]. We used default priors and operators, and ran at least two independent Markov Chain Monte Carlo (MCMC) chains with 40 to 100 million steps, sampling every 10,000th step, using a maximum-likelihood phylogeny as a starting tree. The BEAGLE library was used for accelerated computations [58]. We assessed mixing of MCMC chains and convergence of all parameters using Tracer v1.7 [59]. We used Logcombiner [52] to sample 1,000 trees from the combined posterior trees distribution, after removal of 10% burn-in. A discrete phylogeographic analysis was then performed with a set of 1,000 empirical dated trees obtained from the posterior distribution, as previously described [60]. We used an asymmetric substitution model [53] and considered four geographic locations/regions: Rio de Janeiro state (n = 67), North region (n = 22), Northeast region (n = 52), and Central-West region (n = 7).

Finally, we also investigated changes in CHIKV genetic diversity over time in RJ. We assembled a third dataset, comprehending all Rio de Janeiro sequences belonging to a dominant clade, identified in the previous analysis (n = 63). We used a skygrid prior, as described above. In this case, we also used an informative prior on the root age based on the estimate obtained from the analysis of the full dataset. BEAST analyses were run in duplicate for 20 million generations, sampling every 2,000th state. BEAST XML files and outputs are available in S2 File and on the project GitHub repository (https://github.com/filiperomero2/CHIKV_RJ_2015-2018, last accessed on 30 May 2023).

2.10. Selection analyses and ancestral states reconstruction

Selection analyses were conducted on the ECSA-American alignment with Brazilian sequences described above using MEME (Mixed Effects Model of Evolution) [61] and FEL (fixed effects likelihood) [62] models to detect individual genome sites subjected to episodic and pervasive positive selection on the Datamonkey web server [63,64]. A significance threshold of p < 0.01 was used for analyses. To map positively selected sites along the evolutionary history of Brazilian CHIKV ECSA-American sub-lineage, we performed ancestral sequence reconstruction using TreeTime [65].

3. Results

3.1. State-level chikungunya incidence and transmissibility

The first chikungunya epidemic wave in Rio de Janeiro state occurred in 2016 (Fig 1C), with 16,245 laboratory-confirmed cases. In 2017, fewer cases were reported (n = 3,989), with a nearly constant number of infections in the first semester, decreasing by the end of the year. In early 2018, a sharp increase in chikungunya infections were observed, leading to a larger epidemic with a magnitude greater than the first (n = 24,990 cases). In both 2016 and 2018 waves, cases grew exponentially between January and March, reaching peaks in April. Most confirmed cases occurred in the state’s capital, Rio de Janeiro city (54%; n = 24,636/45,241; S1 Fig). This pattern was most evident in 2016 (87%; n = 14,204/16,245) than in 2017 (44%; n = 1,768/3,989) and 2018 (35%; n = 8,649/24,990). In 2018, while the state capital exhibited the highest incidence, a large number of infections were reported in other municipalities, such as Campos dos Goytacazes (24%; n = 5,968/24,990) and São Gonçalo (21%, n = 5,323/24,990).

To better understand the transmission dynamics of CHIKV ECSA in Rio de Janeiro state, we estimated R0 from notification data. First, we estimated an epidemic growth rate, r, of 1.032 (95% CI: 1.027–1.038) for 2016. Assuming a generation time (GT) of 14 days, we estimated a R0 of 1.56 (95% CI = 1.46–1.67). Sensitivity analysis with different GT distributions generated different R0 values (GT mean = 10 days, R0 = 1.37, 95% CI: 1.31–1.44; GT mean = 20 days, R0 = 1.89, 95% CI: 1.72–2.09) (S2 Fig). Overall, these estimates are similar to those previously obtained for DENV and lower compared to R0 estimates obtained for the ZIKV epidemic in Rio de Janeiro [66].

We then estimated the Rt to track the progress of the epidemic in Rio de Janeiro state (Fig 1D). Noticeably, we observed that between 2016 and mid-2018, high transmissibility periods broadly coincide with periods of relatively high Ae. aegypti transmission potential. This shows that during the study period, the timing of chikungunya recurrence in Rio de Janeiro was at least partly driven by climatic factors such as temperature and humidity that correlate with fluctuations in Ae. aegypti abundance (Figs 1D and S3). As expected, Rt follows a seasonal pattern, reaching the peak values in early 2016 (mean: 2.14, 95% CI: 2.06–2.22), 2017 (mean: 1.45, 95% CI: 1.35–1.56) and 2018 (mean: 1.76, 95% CI: 1.63–1.91). Rt estimates obtained using different window lengths, and GT distributions revealed similar patterns (S4 Fig).

3.2. Molecular detection and whole-genome sequencing of CHIKV from Duque de Caxias municipality

Of the 179 clinical samples from patients presenting symptoms compatible with arbovirus infections in health-care units of the Duque de Caxias municipality, 48.6% (n = 87) tested positive for CHIKV RNA (mean cycle threshold, Ct, was 23.2, range: 14.7 to 33.1), 1.1% (n = 2) tested positive for DENV and 2.8% (n = 5) for ZIKV. We detected CHIKV coinfections with DENV (n = 1) and ZIKV (n = 3). For the CHIKV RNA-positive cases, clinical manifestations included fever (100%, n = 87/87), arthralgia (97.7%, n = 85/87), headache (82.8%, n = 72/87), myalgia (71.3%, n = 62/87), arthritis (62.1%, n = 54/87), conjunctivitis (33.3%, n = 29/87), and exanthema (31%, n = 27/87) (Fig 2A and S3 File). Less frequently, prurience (11.5%, n = 10/87), dyscrasia (3.4%, n = 3/87) and neurological symptoms (2.3%, n = 2/87) were also recorded. As expected, we observed a tendency towards lower values (higher viral loads) in samples collected closer to the dates of symptom onset (Fig 2B). Thirty-four near complete CHIKV genome sequences were generated with an average 90.8% (standard deviation: 6.2%, range: 70.5–98%) genome coverage in relation to the CHIKV genome reference sequence (Table 1). Sequencing coverage was inversely correlated with Ct values, although no strong statistical relationship was inferred on a linear model (p = 0.08; Fig 2C).

Fig 2.

Fig 2

Symptoms distribution, RT-qPCR Ct values dynamics and their correlation with genome sequencing coverage. (A) Distribution of symptoms exhibited by all CHIKV positive patients in the Duque de Caxias cohort. (B) The time lag between symptoms onset and sample collection dates exhibits correlation with RT-qPCR Ct values. As infection proceeds, viral loads decrease (Cts increase) likely due to immunological response. (C) Negative correlation between RT-qPCR Cts and genome sequencing coverage. Sequences characterized from samples with higher viral load (lower Cts) tend to exhibit higher coverage, although no strong statistical correlation was inferred on a linear model (p = 0.08).

3.3. Phylogenetic analyses of the CHIKV ECSA-American lineage

Newly generated sequences clustered within the ECSA-American lineage with maximum statistical support (SH-aLRT = 100; Fig 3A). After removal of outliers, we found a strong correlation between sampling dates and genetic divergence (Fig 3B and 3C; R2 = 0.72). No recombination was detected. Most of the new sequences (n = 28/31) clustered within a dominant clade of sequences from Rio de Janeiro state (named RJ1; n = 74, SH-aLRT = 88.4), while a few (n = 3/31) grouped in a smaller clade (RJ2; n = 4, SH-aLRT = 95.2) together with a publicly available sequence from Rio de Janeiro. Most sequences from Duque de Caxias clustered with sequences from other municipalities, such as Niterói and São João de Meriti, suggesting frequent viral spread within state borders.

Fig 3. Maximum likelihood phylogenetic analysis of global and ECSA-American datasets.

Fig 3

(A) Phylogenetic tree inferred from the global dataset. All new characterized genomes clustered within the ECSA-Br clade. Names of lineages and relevant clades are indicated. SH-aLRT statistical support values for these clades are shown close to their defining nodes (colored in red). (B) Phylogeny inferred from the filtered ECSA-American dataset. Tip shapes are colored according to sampling location (Centre-West region: purple, North region: yellow, Northeast region: red, Rio de Janeiro state: green). Sequences generated in this study are highlighted with red circles around the tip shapes. Clades composed mostly by RJ sequences are indicated along their SH-aLRT support values. (C) The root-to-tip regression plot, which indicates a strong temporal signal (R2 = 0.72, slope = 5.19 x 10−4). Scale bars represent substitutions per site (s/s).

Time scale inferences with both strict and UCLN models results were highly congruent. As the posterior distribution of the coefficient variation of the UCLN model displayed wide variation and included extremely low values (95% BCI: 6.68 x 10−4–0.43), we opted for focusing on the strict model (S2 File). Our time-scaled phylogenetic analysis estimated an evolutionary rate of around 5.72 x 10−4 (95% Bayesian credible interval, BCI, 4.89 x 10−4–6.50 x 10−4) substitutions per site per year and corroborated that the ECSA-American clade emerged in the Northeast region in mid-2014 (mean: 21 July, 95% BCI: 29 May to 25 August; Fig 4A). CHIKV-ECSA-American clade spread to the North and Centre-West regions of Brazil, as well as to Rio de Janeiro state. RJ1 and RJ2 clades result from independent introductions from the Northeast region with location posterior probability support > 99%. In contrast, the tMRCA for RJ1 was estimated in mid-2015 (mean: 7 July, 95% BCI: 4 April to 24 September 2015; clade posterior probability: 0.99), RJ2 tMRCA was dated around mid-2017 (mean: 7 July 2017, 95% BCI: 12 March 2017 to 6 November 2017; clade posterior probability: 1.00). Although we detected a more recent introduction from the Northeast region, our data suggests that the 2018 chikungunya epidemic in Rio de Janeiro was driven mostly by the RJ1 clade that was circulating in Rio de Janeiro since mid-2015.

Fig 4. Bayesian time scaled phylogeographic reconstruction for the clade ECSA-Br.

Fig 4

(A) The molecular clock phylogeny annotated with discrete trait reconstructions. Colors indicate estimated ancestral locations (Centre-West region: purple, North region: yellow, Northeast region: red, Rio de Janeiro state: green). Tip shapes mark sequences generated in this study. The x-axis depicts the timescale, while the density plots indicate the posterior distributions estimated for the age of clades ECSA-American, RJ1 and RJ2. Posterior probabilities for both RJ clades are shown. Positively selected mutations detected with MEME and FEL models (NS1: D351G and NS4: A481D) are exhibited on the branches where they occurred according to the ancestral states reconstruction performed (TreeTime). The inset marks the date of arrival of the index case in the Northeast region. (B) Skygrid reconstruction plot for the clade RJ1. A separate analysis was performed with only RJ sequences from the clade RJ1, allowing the reconstruction of the dynamics of variation of viral effective population size in the state (left y-axis). The analysis reveals CHIKV genetic diversity varied over time, with periods of high diversity matching peaks observed in incidence data (right y-axis).

The demographic pattern of the RJ1 clade inferred through coalescent non-parametric analysis, revealed that virus genetic diversity rose during the 2016 epidemic, declined through 2017, and rose again (Fig 4B). Notably, epidemiological and genetic data independently suggest that 2017 had a much lower number of infections than 2016 and 2018, despite the circulation of locally established lineage (RJ1) and a window of climatic suitability for transmission (Fig 1D).

3.4. Adaptive molecular evolution of CHIKV ECSA-American

Our ancestral reconstruction revealed 93 mutations associated with RJ lineages, of which 75 were synonymous and 18 non-synonymous (S5 Fig). Non-synonymous mutations have been identified in nearly all CHIKV ORFs: nsP1 (R76K, D531G), nsP2 (P16L, G261R, N299S, A545S, V645A, T652I), nsP3 (T422I, R435H), nsP4 (R99Q, I111V, S157C), C (K89R, A264T), E2 (V408I) and E1 (A305T, V669M). MEME and FEL models detected three and two amino acid changes under positive selection with statistical significance (p < 0.01; see also S4 File), respectively. Both models indicate that amino acids nsP1: D531G and nsP4: A481D were under positive selection. Interestingly, nsP4: A481D is a lineage-defining mutation of a clade that comprehends lineage RJ1 and a single sequence from Sergipe state (Northeast region, Accession Number: KY055011) (Figs 4A and S5A). In contrast, the nsP1: D531G amino acid change occurs within a subclade of RJ2, but also emerged multiple independent times within RJ1 (Figs 4A and S5A).

4. Discussion

We provide a detailed picture of the epidemic history of CHIKV ECSA-American in Rio de Janeiro state from 2016 to 2018, which could be divided into three epidemic phases. First, our analyses suggest that CHIKV ECSA was introduced in Rio de Janeiro around mid-2015, causing its first recorded epidemic in 2016, once ZIKV cases started decreasing in the state [67]. We estimated a R0 for CHIKV ECSA-American in Rio de Janeiro to be around 1.56, similar to those reported to CHIKV across other settings [18,6870]. Additionally, our R0 for CHIKV was consistent with estimates for DENV in Rio de Janeiro [66], and lower compared to estimates for Zika [66], which caused large epidemics in Rio de Janeiro between 2015–2016 [71]. However, we then found unusually low CHIKV incidence and genetic diversity in 2017. The implementation of large-scale Wolbachia interventions in Ae. aegypti populations in Rio de Janeiro only started in late 2017 in a single neighborhood (Ilha do Governador); therefore, it is unlikely to explain the observed patterns [72]. Low chikungunya incidences in 2017 were also observed in a large serosurveillance study of blood donors [73]. Thus, we hypothesize that the low number of cases in 2017 can partially be explained by climatic factors since Ae. aegypti suitability, mean temperature, or humidity in 2017 was lower compared to previous and following years. Moreover, the large chikungunya epidemic in Rio de Janeiro in 2018 indicates that the trend observed in 2017 was unlikely to be caused primarily by population immunity. Indeed, surveys found that 18% of seroprevalence against CHIKV in >2,000 participants screened between July and October 2018 [74]. Additional investigations into the dynamics of arbovirus population immunity, including accurate estimates of force of infection, and analysis of data on vector control policies and population behavior, could help better understand the dynamics and evolution of CHIKV transmission in the Americas.

Overall, our results show that CHIKV incidence, Rt, and Ae. aegypti transmission potential display a seasonal pattern and are generally synchronized. Similar trends have been noticed for ZIKV [18,26], and further highlight the interplay between vector ecology, climate and arbovirus disease transmission. Given its major connectivity at the national and international level, Rio de Janeiro is a key hotspot for arbovirus transmission and a location of interest for epidemiological surveillance in Brazil. For instance, several events of dengue lineage replacement were caused by novel lineages initially detected in Rio de Janeiro [27]. In 2018, three different arboviruses circulated in Rio de Janeiro, CHIKV, DENV, and ZIKV, with CHIKV causing the most infections. We noticed a similar scenario in the Duque de Caxias municipality, from which 48.6% were positive for CHIKV and much smaller proportions for ZIKV (2.79%) and DENV (1.11%) in 2018. Overall, clinical symptoms in our cohort were similar to those described elsewhere [75]. However, among the CHIKV RNA-positive cases, we recorded one presenting neurological manifestations. A recent study has shown that neurological signs and symptoms were reported in 39% of CHIKV cases with a fatal outcome [3]. Additional studies are needed to investigate host and viral factors associated with clinical manifestations.

Our genetic analyses confirm that the clade ECSA-American lineage emerged in Northeast Brazil in mid-2014, consistent with the arrival of the index case in Bahia state in late May [16,17]. This lineage then spread to all other regions over the following couple of years, being introduced in Rio de Janeiro around mid-2015, and later in mid-2017. We show that both introductions occurred from the Northeast region, consistent with previous findings [20,21,29]. As the first autochthonous cases of CHIKV in Rio de Janeiro were detected in November 2015, the period of cryptic transmission in the state was between two and seven months, consistent with previous estimates [20,29].

Our analyses show the acquisition of a range of non-synonymous mutations in both non-structural and structural genes of the ECSA-American lineage. Although Ae. albopictus mosquitoes are abundant in Rio de Janeiro [76], none of the new sequences presented the mutations E1:A226V or E2:L210Q, previously associated with increased transmission competence by Ae. albopictus mosquitoes in the Indian Ocean Lineage [11,12]. However, it remains unclear whether other mutations in CHIKV ECSA-American strains are associated with increased transmissibility in Ae. aegypti and/or Ae. albopictus. Notwithstanding, our analyses prove that at least two non-synonymous mutations associated with sequences from Brazil evolved through molecular adaptation: nsP1: D351G and nsP4: A481D. While evidence for positive selection in non-structural genes has already been identified for the CHIKV Asian genotype [77], this is the first report of this phenomenon for CHIKV ECSA. Signals of positive selection in non-structural proteins have also been detected for another alphavirus (Western equine encephalitis virus) in natural settings [78,79], and experiments with chimeric alphaviruses have shown that adaptive mutations in nonstructural proteins are essential for viral replication and infectivity [80]. Nonstructural proteins have also been shown to be preferential targets for adaptive molecular evolution among different flaviviruses [81]. As these new mutations may impact the virus’ biological properties and epidemiology, further studies with cellular and animal models, including Ae. aegypti and Ae. albopictus vector competence surveys, should be performed to clarify their phenotypic impact.

In conclusion, our study sheds light on the epidemiological dynamics of chikungunya in the state of Rio de Janeiro up to 2018. We demonstrate that chikungunya incidence and transmissibility varied seasonally, following trends in Ae. aegypti transmission potential. We also provided first reports of CHIKV ECSA-American epidemiological parameters and identified mutations of interest that evolved under positive selection. We encourage scaling up diagnostic efforts for arboviruses and deployment of effective mosquito control strategies. Larger forthcoming genomic and epidemiological CHIKV-ECSA studies will help to disentangle the impact of virus molecular evolution and adaptation, host population behavior and immunity, and vector ecology to improve public health interventions against arboviruses.

Supporting information

S1 Fig. CHIKV incidence within Rio de Janeiro state.

(A) CHIKV incidence per state region. Rio de Janeiro is officially divided into five intermediate regions, each comprehending between 12 and 26 municipalities (IBGE, https://www.ibge.gov.br/apps/regioes_geograficas/, last accessed 17 August 2022). (B) CHIKV incidence per municipality. As the state comprehends 92 municipalities, and many of them present low incidence levels through the entire period, individual color legends have been omitted. Municipalities that at any point presented weekly incidence above 500 cases were highlighted in the plot (Campos dos Goytacazes, Rio de Janeiro, São Gonçalo).

(TIFF)

S2 Fig. R0 estimates and sensitivity analysis.

R0 estimates obtained with epidemiological data under different generation time distributions (gamma distributions with means 10, 14 and 20, and constant standard deviation: 6.4 days).

(TIFF)

S3 Fig

Time series of climatic variables—(A) 2m temperature, (B) total precipitation and (C) relative humidity—for Rio de Janeiro state between 2014 and 2018. All climatic data was obtained from the ECMWF reanalysis product [34].

(TIFF)

S4 Fig. Rt estimates and sensitivity analysis.

(A) Rt estimate performed with different generation time (GT) distributions (gamma distributions with means 10, 14 and 20, and constant standard deviation: 6.4 days). Colors indicate estimates for different GTs (10: gray, 14: yellow, 20: blue). (B) Rt estimates performed with different sliding window lengths (3 to 8 weeks). Colors indicate estimates for different window lengths (3: salmon, 4: yellow, 5: green, 6: blue, 7: purple, 8: pink). Solid lines indicate mean values and ribbons indicate the 95% confidence intervals. The dashed lines denote the critical epidemic threshold (Rt = 1).

(TIFF)

S5 Fig. TreeTime and HyPhy analysis.

(A) The molecular clock tree had its branches colored according to the ancestral location’s reconstructions. Tip shapes indicate sequences generated in this study. Light gray ticks along branches indicate synonymous mutations, while dark gray ticks mark non-synonymous mutations. Mutations for which evidence of positive selection was found (MEME and FEL models) are marked in red (NS4: A481D) and blue (NS1: D531G). (B) CHIKV genome scheme exhibiting all mutations reconstructed and associated with RJ clades. Non-synonymous mutations are numbered from 1 to 18 and their positions and corresponding amino acid replacements are indicated by black vertical lines. Similarly, vertical gray lines indicate the position of the synonymous mutations inferred. Non-structural and structural open reading frames are colored in dark green and light green, respectively.

(TIFF)

S1 File. Data and R code used in epidemiological analyses.

(ZIP)

S2 File. BEAST xml files and outputs generated in this study.

(ZIP)

S3 File. Clinical data from CHIKV positive patients.

(XLSX)

S4 File. Input and output files of selection analysis with Datamonkey.

(ZIP)

Acknowledgments

We thank the Health Department of the Municipality of Duque de Caxias, RJ, Brazil, which allowed the collection of clinical samples from patients with suspected arboviruses.

Data Availability

The novel viral genome sequences were deposited to NCBI GenBank under Accession Numbers OP312936 to OP312969. Data and code used in this study were made available in supplementary files and on the project GitHub repository at https://github.com/filiperomero2/CHIKV_RJ_2015-2018 and https://github.com/filiperomero2/ViralUnity.

Funding Statement

This research was funded by the Rede Corona-ômica BR MCTI/FINEP affiliated to 116 RedeVírus/MCTI (FINEP 01.20.0029.000462/20, CNPq 404096/2020-4); MEC/CAPES 118 (14/2020 - 23072.211119/2020-10), FINEP (0494/20 01.20.0026.00), UFMG-NB3, FINEP n° 1139/20 (RSA) and FAPERJ (R.S.A 202.922/2018). This project was also partially funded by the Instituto Todos pela Saúde-ITpS (Chamada 01/2021-C1294). CW is supported by Sir Henry Wellcome Postdoctoral Fellowship (Ref 224190/Z/21/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Pialoux G, Gaüzère B-A, Jauréguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007;7: 319–327. doi: 10.1016/S1473-3099(07)70107-X [DOI] [PubMed] [Google Scholar]
  • 2.Chen R, Mukhopadhyay S, Merits A, Bolling B, Nasar F, Coffey LL, et al. ICTV Virus Taxonomy Profile: Togaviridae. J Gen Virol. 2018;99: 761–762. doi: 10.1099/jgv.0.001072 [DOI] [PubMed] [Google Scholar]
  • 3.de Lima STS, de Souza WM, Cavalcante JW, da Silva Candido D, Fumagalli MJ, Carrera J-P, et al. Fatal Outcome of Chikungunya Virus Infection in Brazil. Clin Infect Dis. 2021;73: e2436–e2443. doi: 10.1093/cid/ciaa1038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Nsoesie EO, Kraemer MU, Golding N, Pigott DM, Brady OJ, Moyes CL, et al. Global distribution and environmental suitability for chikungunya virus, 1952 to 2015. Euro Surveill. 2016;21. doi: 10.2807/1560-7917.ES.2016.21.20.30234 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Grubaugh ND, Faria NR, Andersen KG, Pybus OG. Genomic Insights into Zika Virus Emergence and Spread. Cell. 2018;172: 1160–1162. doi: 10.1016/j.cell.2018.02.027 [DOI] [PubMed] [Google Scholar]
  • 6.Volk SM, Chen R, Tsetsarkin KA, Adams AP, Garcia TI, Sall AA, et al. Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol. 2010;84: 6497–6504. doi: 10.1128/JVI.01603-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Pybus OG, Tatem AJ, Lemey P. Virus evolution and transmission in an ever more connected world. Proc Biol Sci. 2015;282: 20142878. doi: 10.1098/rspb.2014.2878 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Charrel RN, de Lamballerie X, Raoult D. Chikungunya outbreaks—the globalization of vectorborne diseases. N Engl J Med. 2007;356: 769–771. doi: 10.1056/NEJMp078013 [DOI] [PubMed] [Google Scholar]
  • 9.Cauchemez S, Ledrans M, Poletto C, Quenel P, de Valk H, Colizza V, et al. Local and regional spread of chikungunya fever in the Americas. Euro Surveill. 2014;19: 20854. doi: 10.2807/1560-7917.es2014.19.28.20854 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet. 2007;370: 1840–1846. doi: 10.1016/S0140-6736(07)61779-6 [DOI] [PubMed] [Google Scholar]
  • 11.Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;3: e201. doi: 10.1371/journal.ppat.0030201 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Tsetsarkin KA, McGee CE, Volk SM, Vanlandingham DL, Weaver SC, Higgs S. Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes. PLoS One. 2009;4: e6835. doi: 10.1371/journal.pone.0006835 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Tsetsarkin KA, Chen R, Leal G, Forrester N, Higgs S, Huang J, et al. Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci U S A. 2011;108: 7872–7877. doi: 10.1073/pnas.1018344108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, de Lamballerie X. Chikungunya in the Americas. The Lancet. 2014. p. 514. doi: 10.1016/S0140-6736(14)60185-9 [DOI] [PubMed] [Google Scholar]
  • 15.Pan American Health Organization (PAHO). Chikungunya. [cited 14 Aug 2022]. Available: https://www.paho.org/en/topics/chikungunya
  • 16.Nunes MRT, Faria NR, de Vasconcelos JM, Golding N, Kraemer MUG, de Oliveira LF, et al. Emergence and potential for spread of Chikungunya virus in Brazil. BMC Med. 2015;13: 102. doi: 10.1186/s12916-015-0348-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Faria NR, Lourenço J, de Cerqueira EM, de Lima MM, Pybus O, Alcantara LCJ. Epidemiology of Chikungunya Virus in Bahia, Brazil, 2014-2015Vaccine Hesitancy CollectionPLOS Science Reddit AMAHealthMap EbolaNew Twitter. PLoS Curr. 2016. doi: 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Naveca FG, Claro I, Giovanetti M, de Jesus JG, Xavier J, Iani FC de M, et al. Genomic, epidemiological and digital surveillance of Chikungunya virus in the Brazilian Amazon. PLoS Negl Trop Dis. 2019;13: e0007065. doi: 10.1371/journal.pntd.0007065 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Charlys da Costa A, Thézé J, Komninakis SCV, Sanz-Duro RL, Felinto MRL, Moura LCC, et al. Spread of Chikungunya Virus East/Central/South African Genotype in Northeast Brazil. Emerg Infect Dis. 2017;23: 1742–1744. doi: 10.3201/eid2310.170307 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Xavier J, Giovanetti M, Fonseca V, Thézé J, Gräf T, Fabri A, et al. Circulation of chikungunya virus East/Central/South African lineage in Rio de Janeiro, Brazil. PLOS ONE. 2019. p. e0217871. doi: 10.1371/journal.pone.0217871 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Souza TML, Vieira YR, Delatorre E, Barbosa-Lima G, Luiz RLF, Vizzoni A, et al. Emergence of the East-Central-South-African genotype of Chikungunya virus in Brazil and the city of Rio de Janeiro may have occurred years before surveillance detection. Sci Rep. 2019;9: 2760. doi: 10.1038/s41598-019-39406-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Vasconcellos AF, Silva JMF, de Oliveira AS, Prado PS, Nagata T, Resende RO. Genome sequences of chikungunya virus isolates circulating in midwestern Brazil. Arch Virol. 2019;164: 1205–1208. doi: 10.1007/s00705-019-04174-4 [DOI] [PubMed] [Google Scholar]
  • 23.de Souza WM, de Lima STS, Simões Mello LM, Candido DS, Buss L, Whittaker C, et al. Spatiotemporal dynamics and recurrence of chikungunya virus in Brazil: an epidemiological study. Lancet Microbe. 2023. doi: 10.1016/S2666-5247(23)00033-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gräf T, Vazquez C, Giovanetti M, de Bruycker-Nogueira F, Fonseca V, Claro IM, et al. Epidemiologic History and Genetic Diversity Origins of Chikungunya and Dengue Viruses, Paraguay. Emerg Infect Dis. 2021;27: 1393–1404. doi: 10.3201/eid2705.204244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.White SK, Mavian C, Salemi M, Morris JG Jr, Elbadry MA, Okech BA, et al. A new “American” subgroup of African-lineage Chikungunya virus detected in and isolated from mosquitoes collected in Haiti, 2016. PLoS One. 2018;13: e0196857. doi: 10.1371/journal.pone.0196857 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Faria NR, Quick J, Claro IM, Thézé J, de Jesus JG, Giovanetti M, et al. Establishment and cryptic transmission of Zika virus in Brazil and the Americas. Nature. 2017;546: 406–410. doi: 10.1038/nature22401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Torres MC, de Bruycker Nogueira F, Fernandes CA, Louzada Silva Meira G, Ferreira de Aguiar S, Chieppe AO, et al. Re-introduction of dengue virus serotype 2 in the state of Rio de Janeiro after almost a decade of epidemiological silence. PLoS One. 2019;14: e0225879. doi: 10.1371/journal.pone.0225879 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Brasil, 2019. Boletim Epidemiológico—Monitoramento dos casos de dengue, febre de chikungunya e doença aguda pelo vírus Zika até a Semana Epidemiológica 52 de 2018. Ministério da Saúde. Secretaria de Vigilância em Saúde, report no.: 4.
  • 29.Fabri AA, Rodrigues CDDS, Santos CCD, Chalhoub FLL, Sampaio SA, Faria NR da C, et al. Co-Circulation of Two Independent Clades and Persistence of CHIKV-ECSA Genotype during Epidemic Waves in Rio de Janeiro, Southeast Brazil. Pathogens. 2020;9. doi: 10.3390/pathogens9120984 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Cori A, Ferguson NM, Fraser C, Cauchemez S. A new framework and software to estimate time-varying reproduction numbers during epidemics. Am J Epidemiol. 2013;178: 1505–1512. doi: 10.1093/aje/kwt133 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Salje H, Lessler J, Paul KK, Azman AS, Rahman MW, Rahman M, et al. How social structures, space, and behaviors shape the spread of infectious diseases using chikungunya as a case study. Proc Natl Acad Sci U S A. 2016;113: 13420–13425. doi: 10.1073/pnas.1611391113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.R Core Team (2022). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/. [Google Scholar]
  • 33.Obadia T, Haneef R, Boëlle P-Y. The R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks. BMC Med Inform Decis Mak. 2012;12: 147. doi: 10.1186/1472-6947-12-147 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Copernicus climate data store. [cited 23 Feb 2023]. Available: https://cds.climate.copernicus.eu/cdsapp#!/dataset/reanalysis-era5-single-levels?tab=overview
  • 35.Alduchov OA, Eskridge RE. Improved Magnus Form Approximation of Saturation Vapor Pressure. J Appl Meteorol Climatol. 1996;35: 601–609. [Google Scholar]
  • 36.August E. F. Ueber die Berechnung der Expansivkraft des Wasserdunstes. Ann. Phys. Chem. 1828;13: 122–137. [Google Scholar]
  • 37.Magnus G. Versuche über die Spannkräfte des Wasserdampfs. Ann. Phys. Chem. 1844;61: 225–247. [Google Scholar]
  • 38.Obolski U, Perez PN, Villabona-Arenas CJ, Thézé J, Faria NR, Lourenço J. MVSE: An R-package that estimates a climate-driven mosquito-borne viral suitability index. Methods Ecol Evol. 2019;10: 1357–1370. doi: 10.1111/2041-210X.13205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Quick J, Grubaugh ND, Pullan ST, Claro IM, Smith AD, Gangavarapu K, et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat Protoc. 2017;12: 1261–1276. doi: 10.1038/nprot.2017.066 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30: 2114–2120. doi: 10.1093/bioinformatics/btu170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9: 357–359. doi: 10.1038/nmeth.1923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25: 2078–2079. doi: 10.1093/bioinformatics/btp352 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Li H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics. 2011;27: 2987–2993. doi: 10.1093/bioinformatics/btr509 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26: 841–842. doi: 10.1093/bioinformatics/btq033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Sayers EW, Bolton EE, Brister JR, Canese K, Chan J, Comeau DC, et al. Database resources of the national center for biotechnology information. Nucleic Acids Res. 2022;50: D20–D26. doi: 10.1093/nar/gkab1112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30: 772–780. doi: 10.1093/molbev/mst010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, von Haeseler A, et al. IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era. Mol Biol Evol. 2020;37: 1530–1534. doi: 10.1093/molbev/msaa015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Kalyaanamoorthy S, Minh BQ, Wong TKF, von Haeseler A, Jermiin LS. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat Methods. 2017;14: 587–589. doi: 10.1038/nmeth.4285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Guindon S, Dufayard J-F, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59: 307–321. doi: 10.1093/sysbio/syq010 [DOI] [PubMed] [Google Scholar]
  • 50.Martin DP, Murrell B, Golden M, Khoosal A, Muhire B. RDP4: Detection and analysis of recombination patterns in virus genomes. Virus Evol. 2015;1: vev003. doi: 10.1093/ve/vev003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Rambaut A, Lam TT, Max Carvalho L, Pybus OG. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen). Virus Evol. 2016;2: vew007. doi: 10.1093/ve/vew007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Suchard MA, Lemey P, Baele G, Ayres DL, Drummond AJ, Rambaut A. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 2018;4: vey016. doi: 10.1093/ve/vey016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Lemey P, Rambaut A, Drummond AJ, Suchard MA. Bayesian phylogeography finds its roots. PLoS Comput Biol. 2009;5: e1000520. doi: 10.1371/journal.pcbi.1000520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Hasegawa M, Yano T-A, Kishino H. A New Molecular Clock of Mitochondrial DNA and the Evolution of Hominoids. Proc Jpn Acad Ser B Phys Biol Sci. 1984;60: 95–98. [Google Scholar]
  • 55.Yang Z. Maximum likelihood phylogenetic estimation from DNA sequences with variable rates over sites: approximate methods. J Mol Evol. 1994;39: 306–314. doi: 10.1007/BF00160154 [DOI] [PubMed] [Google Scholar]
  • 56.Gill MS, Lemey P, Faria NR, Rambaut A, Shapiro B, Suchard MA. Improving Bayesian population dynamics inference: a coalescent-based model for multiple loci. Mol Biol Evol. 2013;30: 713–724. doi: 10.1093/molbev/mss265 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Drummond AJ, Ho SYW, Phillips MJ, Rambaut A. Relaxed phylogenetics and dating with confidence. PLoS Biol. 2006;4: e88. doi: 10.1371/journal.pbio.0040088 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Ayres DL, Darling A, Zwickl DJ, Beerli P, Holder MT, Lewis PO, et al. BEAGLE: an application programming interface and high-performance computing library for statistical phylogenetics. Syst Biol. 2012;61: 170–173. doi: 10.1093/sysbio/syr100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Rambaut A, Drummond AJ, Xie D, Baele G, Suchard MA. Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7. Syst Biol. 2018;67: 901–904. doi: 10.1093/sysbio/syy032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Candido DS, Claro IM, de Jesus JG, Souza WM, Moreira FRR, Dellicour S, et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science. 2020;369: 1255–1260. doi: 10.1126/science.abd2161 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond SL. Detecting individual sites subject to episodic diversifying selection. PLoS Genet. 2012;8: e1002764. doi: 10.1371/journal.pgen.1002764 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Kosakovsky Pond SL, Frost SDW. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol. 2005;22: 1208–1222. doi: 10.1093/molbev/msi105 [DOI] [PubMed] [Google Scholar]
  • 63.Weaver S, Shank SD, Spielman SJ, Li M, Muse SV, Kosakovsky Pond SL. Datamonkey 2.0: A Modern Web Application for Characterizing Selective and Other Evolutionary Processes. Mol Biol Evol. 2018;35: 773–777. doi: 10.1093/molbev/msx335 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Kosakovsky Pond SL, Poon AFY, Velazquez R, Weaver S, Hepler NL, Murrell B, et al. HyPhy 2.5-A Customizable Platform for Evolutionary Hypothesis Testing Using Phylogenies. Mol Biol Evol. 2020;37: 295–299. doi: 10.1093/molbev/msz197 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Sagulenko P, Puller V, Neher RA. TreeTime: Maximum-likelihood phylodynamic analysis. Virus Evol. 2018;4: vex042. doi: 10.1093/ve/vex042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Villela DAM, Bastos LS, DE Carvalho LM, Cruz OG, Gomes MFC, Durovni B, et al. Zika in Rio de Janeiro: Assessment of basic reproduction number and comparison with dengue outbreaks. Epidemiol Infect. 2017;145: 1649–1657. doi: 10.1017/S0950268817000358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Freitas LP, Cruz OG, Lowe R, Sá Carvalho M. Space-time dynamics of a triple epidemic: dengue, chikungunya and Zika clusters in the city of Rio de Janeiro. Proc Biol Sci. 2019;286: 20191867. doi: 10.1098/rspb.2019.1867 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Salje H, Cauchemez S, Alera MT, Rodriguez-Barraquer I, Thaisomboonsuk B, Srikiatkhachorn A, et al. Reconstruction of 60 Years of Chikungunya Epidemiology in the Philippines Demonstrates Episodic and Focal Transmission. J Infect Dis. 2016;213: 604–610. doi: 10.1093/infdis/jiv470 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Perkins TA, Alex Perkins T, Metcalf CJE, Grenfell BT, Tatem AJ. Estimating Drivers of Autochthonous Transmission of Chikungunya Virus in its Invasion of the Americas. PLoS Currents. 2015. doi: 10.1371/currents.outbreaks.a4c7b6ac10e0420b1788c9767946d1fc [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Robinson M, Conan A, Duong V, Ly S, Ngan C, Buchy P, et al. A model for a chikungunya outbreak in a rural Cambodian setting: implications for disease control in uninfected areas. PLoS Negl Trop Dis. 2014;8: e3120. doi: 10.1371/journal.pntd.0003120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.de Oliveira WK, Carmo EH, Henriques CM, Coelho G, Vazquez E, Cortez-Escalante J, et al. Zika Virus Infection and Associated Neurologic Disorders in Brazil. N Engl J Med. 2017;376: 1591–1593. doi: 10.1056/NEJMc1608612 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Ribeiro Dos Santos G, Durovni B, Saraceni V, Souza Riback TI, Pinto SB, Anders KL, et al. Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio de Janeiro, Brazil: a spatiotemporal modelling study. Lancet Infect Dis. 2022;22: 1587–1595. doi: 10.1016/S1473-3099(22)00436-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Custer B, Grebe E, Buccheri R, Bakkour S, Stone M, Capuani L, et al. Surveillance for Zika, chikungunya and dengue virus incidence and RNAemia in blood donors at four Brazilian blood centers during 2016–2019. J Infect Dis. 2022. doi: 10.1093/infdis/jiac173 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Périssé ARS, Souza-Santos R, Duarte R, Santos F, de Andrade CR, Rodrigues NCP, et al. Zika, dengue and chikungunya population prevalence in Rio de Janeiro city, Brazil, and the importance of seroprevalence studies to estimate the real number of infected individuals. PLoS One. 2020;15: e0243239. doi: 10.1371/journal.pone.0243239 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Mascarenhas M, Garasia S, Berthiaume P, Corrin T, Greig J, Ng V, et al. A scoping review of published literature on chikungunya virus. PLoS One. 2018;13: e0207554. doi: 10.1371/journal.pone.0207554 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Kraemer MUG, Reiner RC Jr, Brady OJ, Messina JP, Gilbert M, Pigott DM, et al. Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus. Nat Microbiol. 2019;4: 854–863. doi: 10.1038/s41564-019-0376-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Sahadeo NSD, Allicock OM, De Salazar PM, Auguste AJ, Widen S, Olowokure B, et al. Understanding the evolution and spread of chikungunya virus in the Americas using complete genome sequences. Virus Evol. 2017;3: vex010. doi: 10.1093/ve/vex010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Bergren NA, Auguste AJ, Forrester NL, Negi SS, Braun WA, Weaver SC. Western equine encephalitis virus: evolutionary analysis of a declining alphavirus based on complete genome sequences. J Virol. 2014;88: 9260–9267. doi: 10.1128/JVI.01463-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Bergren NA, Haller S, Rossi SL, Seymour RL, Huang J, Miller AL, et al. “Submergence” of Western equine encephalitis virus: Evidence of positive selection argues against genetic drift and fitness reductions. PLoS Pathog. 2020;16: e1008102. doi: 10.1371/journal.ppat.1008102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Teppor M, Žusinaite E, Karo-Astover L, Omler A, Rausalu K, Lulla V, et al. Semliki Forest Virus Chimeras with Functional Replicase Modules from Related Alphaviruses Survive by Adaptive Mutations in Functionally Important Hot Spots. J Virol. 2021;95: e0097321. doi: 10.1128/JVI.00973-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Sironi M, Forni D, Clerici M, Cagliani R. Nonstructural Proteins Are Preferential Positive Selection Targets in Zika Virus and Related Flaviviruses. PLoS Negl Trop Dis. 2016;10: e0004978. doi: 10.1371/journal.pntd.0004978 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011536.r001

Decision Letter 0

Elvina Viennet, Qu Cheng

25 May 2023

Dear Mr. Moreira,

Thank you very much for submitting your manuscript "Epidemiological and genomic investigation of chikungunya virus in Rio de Janeiro state, Brazil, between 2015 and 2018" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

According to the reviewers, the current research is valuable and well-conducted. In the revised version, clarifications of novelty of the current research when compared to other similar studies in the same geographic region, the validity of the selected priors for the phylogenetic analyses, and the availability of various dataset should be made.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Qu Cheng, Ph.D.

Guest Editor

PLOS Neglected Tropical Diseases

Elvina Viennet

Section Editor

PLOS Neglected Tropical Diseases

***********************

According to the reviewers, the current research is valuable and well-conducted. They also commented on the novelty of the current research when compared to other similar studies in the same geographic region, the validity of the selected priors for the phylogenetic analyses, the availability of various dataset, etc.

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #2: Minor Revision

Reviewer #3: A detailed description of the process to support the research findings

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: Major Revision

Reviewer #3: Epidemiology and modeling – recommend to update information (if available)

• the case-fatality ratio?

• the case-hospitalization ratio?

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: Major Revision

Reviewer #3: Recommend to strengthen discussion on spatial analysis:

• Not all hotspots are equal, as brought up in a recent paper on a dengue-related risk study that locations of mass public transit such as train stations have known to be hotpots for dengue transmission compared to homes in urban regions (Lefebvre et al., ijerph 2022)

• Comparisons between neighborhoods: are there any data on differences in R0 for different regions of Rio de Janeiro e.g. comparing transmissibility of CHIKV in favelas versus suburbia

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: Minor Revision

Reviewer #2: Minor Revision

Reviewer #3: Accept

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: Moreira et al. investigated the transmission dynamics of the chikungunya virus in Rio de Janeiro state, Brazil, between 2015 and 2018 in this study.

Minor comments:

Could the authors provide an explanation for why they chose the strict molecular clock model and a flexible skygrid tree prior for the Bayesian phylogenetic analyses?

Could the authors include more information about the various datasets they constructed for each analysis?

Although the authors have provided input and R codes for the epi-analysis, I would like to see all input, metadata, and output files for each generated figure (F1-4 and Fig S1-4) publicly accessible in a repository such as GitHub before acceptance. I hope the authors recognize that this is essential for open-access science and reproducibility.

Reviewer #2: Moreira FRR et al. revealed the epidemic and evolutionary history of Chikungunya virus in Rio de Janeiro state from 2016 to 2018. This is a valuable approach, and this manuscript uses a dataset that has a lot of potential for future work. I have several concerns and comments about the present analysis.

1. Previous studies have documented the epidemiological and evolution characteristics of Chikungunya virus in the city of Rio de Janeiro. Therefore, the author needs to highlight the innovative points worth publishing in this article.

(1) Souza, T.M.L., Vieira, Y.R., Delatorre, E. et al. Emergence of the East-Central-South-African genotype of Chikungunya virus in Brazil and the city of Rio de Janeiro may have occurred years before surveillance detection. Sci Rep 9, 2760 (2019). https://doi.org/10.1038/s41598-019-39406-9

(2) Xavier J, Giovanetti M, Fonseca V, Thézé J, Gräf T, Fabri A, Goes de Jesus J, Lima de Mendonça MC, Damasceno Dos Santos Rodrigues C, Mares-Guia MA, Cardoso Dos Santos C, Fraga de Oliveira Tosta S, Candido D, Ribeiro Nogueira RM, Luiz de Abreu A, Kleber Oliveira W, Campelo de Albuquerque CF, Chieppe A, de Oliveira T, Brasil P, Calvet G, Carvalho Sequeira P, Rodrigues Faria N, Bispo de Filippis AM, Alcantara LCJ. Circulation of chikungunya virus East/Central/South African lineage in Rio de Janeiro, Brazil. PLoS One. 2019 Jun 11;14(6):e0217871.

2. More information would be obtained if the dynamic pattern of the Chikungunya virus could be further explored based on the kinetic mechanism model, which integrated the epidemiological data, environmental data and molecular data in one model. The authors should discuss this topic in depth.

Henderson AD, Kama M, Aubry M, Hue S, Teissier A, Naivalu T, Bechu VD, Kailawadoko J, Rabukawaqa I, Sahukhan A, Hibberd ML, Nilles EJ, Funk S, Whitworth J, Watson CH, Lau CL, Edmunds WJ, Cao-Lormeau VM, Kucharski AJ. Interactions between timing and transmissibility explain diverse flavivirus dynamics in Fiji. Nat Commun. 2021 Mar 15;12(1):1671.

3. The authors analyze the possible causes of low prevalence of Chikungunya virus in 2017 compared with 2016 and 2018, in the discussion section, and concluded that the trend observed in 2017 was unlikely to be caused by population immunity. Rather, it is more likely to be caused by environmental factors. Theoretically, the 2016 pandemic would have led to a reduction in the susceptible population, which in turn reduced the intensity of the pandemic in 2017. It is very important to better distinguish the role of each driver.

4. The author hypothesized that the low number of cases in 2017 can partially be explained by climatic factors since Ae. aegypti suitability, mean temperature, or humidity in 2017 was lower compared to previous and following years (page 22). The authors only presented the index P in Fig.1, however, there was no detailed description of the index P and its relation to Rt value in the Result part. Besides, the author mentioned the potential drivers may be mean temperature, or humidity. Can the author place the time-series of mean temperature, humidity and precipitation in the supplementary material?

5. The line number is missing in the manuscript.

6. The results regarding to the clinical presentation and the genome sequencing appear discordant when placed together.

Reviewer #3: The authors did a great job in analyzing the impact of CHIKV during an outbreak in Rio de Janeiro using scalable data such as R(o) and R(t). The authors have brought up under introduction that urbanization is a contributor to CHIKV transmission and its diversity. Adding additional statements (or analysis) under discussion such as spatial analysis stratified by regions within Rio would enrich the conclusions, providing insight into the socioeconomic determinants that may contribute to the overall transmissibility of CHIKV-ECSA in a hyper-urbanized city such as Rio de Janeiro.

Introduction - “Chikungunya’s geographic distribution – particularly of Asian, IOL and ECSA lineages has been expanding rapidly over the last 20 years probably due rapid urbanization, globalization of trade, and virus evolution and adaptation to local variation in the distribution of vector species”

• To check for a more fitting reference for this statement

• “Due to air and fluvial connectivity and high mosquito climatic suitability” - To clarify on the suitable climatic conditions in Rio de Janeiro

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011536.r003

Decision Letter 1

Elvina Viennet, Qu Cheng

17 Jul 2023

Dear Mr. Moreira,

We are pleased to inform you that your manuscript 'Epidemiological and genomic investigation of chikungunya virus in Rio de Janeiro state, Brazil, between 2015 and 2018' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Qu Cheng, Ph.D.

Guest Editor

PLOS Neglected Tropical Diseases

Elvina Viennet

Section Editor

PLOS Neglected Tropical Diseases

***********************************************************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The authors have thoroughly addressed all the comments raised during the initial round of revision. The resulting manuscript appears to be exceptionally well-designed and is deemed suitable for publication.

Reviewer #2: Yes

Reviewer #3: (No Response)

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: The authors have thoroughly addressed all the comments raised during the initial round of revision. The resulting manuscript appears to be exceptionally well-designed and is deemed suitable for publication.

Reviewer #2: Yes

Reviewer #3: (No Response)

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: The authors have thoroughly addressed all the comments raised during the initial round of revision. The resulting manuscript appears to be exceptionally well-designed and is deemed suitable for publication.

Reviewer #2: Yes

Reviewer #3: (No Response)

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: The authors have thoroughly addressed all the comments raised during the initial round of revision. The resulting manuscript appears to be exceptionally well-designed and is deemed suitable for publication.

Reviewer #2: Accept

Reviewer #3: (No Response)

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: The authors have thoroughly addressed all the comments raised during the initial round of revision. The resulting manuscript appears to be exceptionally well-designed and is deemed suitable for publication.

Reviewer #2: no comments

Reviewer #3: Based on their revisions, I believe that authors have aptly revised their work to reflect our suggested comments.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011536.r004

Acceptance letter

Elvina Viennet, Qu Cheng

25 Sep 2023

Dear Mr. Moreira,

We are delighted to inform you that your manuscript, "Epidemiological and genomic investigation of chikungunya virus in Rio de Janeiro state, Brazil, between 2015 and 2018," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. CHIKV incidence within Rio de Janeiro state.

    (A) CHIKV incidence per state region. Rio de Janeiro is officially divided into five intermediate regions, each comprehending between 12 and 26 municipalities (IBGE, https://www.ibge.gov.br/apps/regioes_geograficas/, last accessed 17 August 2022). (B) CHIKV incidence per municipality. As the state comprehends 92 municipalities, and many of them present low incidence levels through the entire period, individual color legends have been omitted. Municipalities that at any point presented weekly incidence above 500 cases were highlighted in the plot (Campos dos Goytacazes, Rio de Janeiro, São Gonçalo).

    (TIFF)

    S2 Fig. R0 estimates and sensitivity analysis.

    R0 estimates obtained with epidemiological data under different generation time distributions (gamma distributions with means 10, 14 and 20, and constant standard deviation: 6.4 days).

    (TIFF)

    S3 Fig

    Time series of climatic variables—(A) 2m temperature, (B) total precipitation and (C) relative humidity—for Rio de Janeiro state between 2014 and 2018. All climatic data was obtained from the ECMWF reanalysis product [34].

    (TIFF)

    S4 Fig. Rt estimates and sensitivity analysis.

    (A) Rt estimate performed with different generation time (GT) distributions (gamma distributions with means 10, 14 and 20, and constant standard deviation: 6.4 days). Colors indicate estimates for different GTs (10: gray, 14: yellow, 20: blue). (B) Rt estimates performed with different sliding window lengths (3 to 8 weeks). Colors indicate estimates for different window lengths (3: salmon, 4: yellow, 5: green, 6: blue, 7: purple, 8: pink). Solid lines indicate mean values and ribbons indicate the 95% confidence intervals. The dashed lines denote the critical epidemic threshold (Rt = 1).

    (TIFF)

    S5 Fig. TreeTime and HyPhy analysis.

    (A) The molecular clock tree had its branches colored according to the ancestral location’s reconstructions. Tip shapes indicate sequences generated in this study. Light gray ticks along branches indicate synonymous mutations, while dark gray ticks mark non-synonymous mutations. Mutations for which evidence of positive selection was found (MEME and FEL models) are marked in red (NS4: A481D) and blue (NS1: D531G). (B) CHIKV genome scheme exhibiting all mutations reconstructed and associated with RJ clades. Non-synonymous mutations are numbered from 1 to 18 and their positions and corresponding amino acid replacements are indicated by black vertical lines. Similarly, vertical gray lines indicate the position of the synonymous mutations inferred. Non-structural and structural open reading frames are colored in dark green and light green, respectively.

    (TIFF)

    S1 File. Data and R code used in epidemiological analyses.

    (ZIP)

    S2 File. BEAST xml files and outputs generated in this study.

    (ZIP)

    S3 File. Clinical data from CHIKV positive patients.

    (XLSX)

    S4 File. Input and output files of selection analysis with Datamonkey.

    (ZIP)

    Attachment

    Submitted filename: CHIKV_Rio_2014-2018_PNTD_review_20230624.docx

    Data Availability Statement

    The novel viral genome sequences were deposited to NCBI GenBank under Accession Numbers OP312936 to OP312969. Data and code used in this study were made available in supplementary files and on the project GitHub repository at https://github.com/filiperomero2/CHIKV_RJ_2015-2018 and https://github.com/filiperomero2/ViralUnity.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES